Table 3. Adverse events in subjects treated with fludarabine and methoxyamine.
Toxicity | All Grades (%) | Grade 3 – 4 (%) | ||
---|---|---|---|---|
Hematologic | N | % | N | % |
Leukopenia | 17 | 85 | 10 | 50 |
Neutropenia | 15 | 75 | 12 | 60 |
Anemia | 20 | 100 | 8 | 40 |
Thrombocytopenia | 13 | 65 | 5 | 25 |
Lymphopenia | 16 | 80 | 14 | 70 |
Gastrointestinal | ||||
Anorexia | 10 | 50 | 0 | 0 |
Constipation | 9 | 45 | 0 | 0 |
Diarrhea | 5 | 25 | 1 | 5 |
Nausea | 13 | 65 | 0 | 0 |
Vomiting | 5 | 25 | 0 | 0 |
Neurologic | ||||
Insomnia | 7 | 35 | 1 | 5 |
Dizziness | 2 | 10 | 0 | 0 |
Paresthesias | 10 | 50 | 0 | 0 |
Pain | 8 | 40 | 1 | 5 |
Respiratory | ||||
Cough | 2 | 10 | 0 | 0 |
Dyspnea | 7 | 35 | 0 | 0 |
General | ||||
Fatigue | 17 | 85 | 0 | 0 |
Cutaneous/Dermatologic | ||||
Alopecia | 3 | 15 | 0 | 0 |
Erythema | 2 | 10 | 0 | 0 |
Pruritus | 2 | 10 | 0 | 0 |
Infectious | ||||
Fever | 6 | 30 | 1 | 5 |
Infection | 5 | 25 | 3 | 15 |
Cardiovascular | ||||
Edema | 3 | 15 | 0 | 0 |
Laboratory | ||||
Hyperbilirubinemia | 8 | 40 | 0 | 0 |
Hypokalemia | 3 | 15 | 0 | 0 |
Hyperuricemia without TLS | 3 | 15 | 1 | 5 |
Hypoalbuminemia | 7 | 35 | 1 | 5 |
Hyponatremia | 8 | 40 | 0 | 0 |
Hypocalcemia | 11 | 55 | 0 | 0 |
Transaminase elevation | 5 | 25 | 1 | 5 |
Creatinine elevation | 5 | 25 | 0 | 0 |
Haptoglobin decrease | 6 | 30 | 0 | 0 |